We are live on ! Find out more
BFRA

Biofrontera AG American Depositary Shares
BFRA

Delisted

BFRA was delisted on the 4th of March, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Biofrontera AG American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $47K → $0 (-$47K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
–
Holders Change
-3
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$44K
2
UBS Group
UBS Group
Switzerland
-$2K
3
Osaic Holdings
Osaic Holdings
Arizona
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
– -$44K -14,900 Closed
UBS Group
2
UBS Group
Switzerland
– -$2K -730 Closed
Osaic Holdings
3
Osaic Holdings
Arizona
– -$1K -200 Closed

BFRA Hedge Fund Activity: Q1 2022 in Review

0 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Biofrontera AG American Depositary Shares (BFRA) for Q1 2022, worth a combined $0 — down 100% from $47K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BFRA and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Morgan Stanley, exiting entirely with an estimated $44K sold.

  • 0 institutional investors held Biofrontera AG American Depositary Shares (BFRA) as of Q1 2022, down from 3 in Q4 2021.
  • Funds reported $0 of Biofrontera AG American Depositary Shares stock for Q1 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Biofrontera AG American Depositary Shares positions in Q1 2022 and 3 closed out, a net change of -3 holders.
  • The largest Biofrontera AG American Depositary Shares seller in Q1 2022 was Morgan Stanley, an estimated $44K sold.

Based on aggregated 13F filings for Q1 2022.